Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter study
Martin Salzmann, Ulrike Leiter, Carmen Loquai, Lisa Zimmer, Selma Ugurel, Ralf Gutzmer, Kai‐Martin Thoms, Alexander Enk, Jessica C. Hassel
Topics & Concepts
MedicineNivolumabInternal medicineOncologyRetrospective cohort studyPembrolizumabToxicityCohortCancerSurgeryImmunotherapyNonmelanoma Skin Cancer StudiesCutaneous Melanoma Detection and ManagementCancer Immunotherapy and Biomarkers